One third of patients don't reach desired LDL cholesterol levels while taking Statins Hina Zahid19 May 2019 7:20 PM ISTOne-third of patients on statins don't reach desired low-density lipoprotein cholesterol (LDL-C)levels, finds a new study. The results are alarming...
1 in 10 young patients with MI will have familial hypercholesterolemia: JACC Study Medha Baranwal Baranwal20 May 2019 8:28 PM ISTUSA: Clinically defined familial hypercholesterolemia (FH) is prevalent in nearly 10% of young adults with myocardial infarction (MI), according to a...
Cholesterol Management: ACC/AHA Updates Guideline Dr. Kamal Kant Kohli Kohli26 May 2019 7:00 PM ISTThe American College of Cardiology/American Heart Association (ACC/AHA) task force on clinical practice guidelines has updated its 2013 cholesterol...
High LDL cholesterol increases risk for early-onset Alzheimer disease Medha Baranwal Baranwal30 May 2019 7:20 PM ISTUSA: A recent study has shed light on increased LDL cholesterol being a possible risk factor for early-onset Alzheimer disease (EOAD).The study,...
Lower LDL cholesterol leads to nerve damage in patients with type 2 diabetes: JAMA Medha Baranwal Baranwal7 Jun 2019 8:28 PM ISTGermany: LDL (low-density lipoprotein) cholesterol, termed as the bad cholesterol has a beneficial role in maintaining the nerve function and healing...
Familial hypercholesterolemia: Independent risk factor for MACCE in young patients, finds study Deepanjana Sarkar20 Jun 2019 8:28 PM ISTFamilial hypercholesterolemia (FH), characterized by high blood levels of Low-Density Lipoprotein Cholesterol i.e LDL-Cholesterol, is an independent...
FDA's 1999 claim of soy as cholesterol lowering diet still valid, finds JAMA study Medha Baranwal Baranwal4 July 2019 8:10 PM ISTCanada: A recent study published in the JAMA journal has backed FDA's 1999 heart health claims of the cholesterol-lowering effect of soy protein,...
Bempedoic Acid / Ezetimibe Combo significantly lowers LDL-C and hsCRP, finds clinical trial Medha Baranwal Baranwal2 Aug 2019 8:20 PM ISTBempedoic Acid / Ezetimibe combo significantly lowers LDL-C and hsCRP, finds a recent study. A fixed-dose combination (FDC) tablet of bempedoic...
PCSK9 inhibitor Alirocumab effectively reduces high LDL-C in Type 2 Diabetes patients Deepanjana Sarkar6 Aug 2019 8:20 PM ISTAlirocumab (a PCSK9 inhibitor) 300 mg for 4 Weeks in Type 2 diabetes patients reduces low-density lipoprotein cholesterol effectively, revealed a...
Inclisiran is twice-yearly potent injectable LDL cholesterol lowering drug reveals Phase 3 clinical trial Deepanjana Sarkar8 Sept 2019 8:28 PM ISTInclisiran is new twice-yearly effective and potent injectable LDL cholesterol-lowering drug, according to a clinical trial.The results of phase 3...
Statin therapy in patients with borderline ASCVD risk provides lifetime health benefits: JAMA Study Medha Baranwal Baranwal9 Sept 2019 8:28 PM ISTDelhi: Lifetime statin treatment in patients with borderline atherosclerotic cardiovascular disease (ASCVD) risk and low-density lipoprotein...
Inclisiran has sustained LDL-C lowering potential with twice a year dosing: JAMA Study Medha Baranwal Baranwal25 Sept 2019 8:28 PM ISTLondon, England: Lowering low density lipoprotein cholesterol (LDL-C) is key to a healthy heart and preventing cardiovascular disease. Statins are the...
